Осложнения антиретровирусной терапии и их коррекция в периоперационном периоде у ВИЧ-инфицированных беременных
https://doi.org/10.15360/1813-9779-2011-3-75
Аннотация
В обзоре представлены сведения об особенностях течения периоперационного периода у ВИЧ-инфицированных пациенток, получающих антиретровирусную терапию. Описаны возможные осложнения, возникающие при приеме ан-тиретровирусных препаратов и пути их коррекции.
Список литературы
1. Jamieson D. J, Read J. S., Kourtis A. P. et al.
2. Read J. S., Newell M. L.Efficacy and safety of cesarean delivery for prevention of mother-to-child transmission of HIV-1. Cochrane Database Syst. Rev. 2005; 19 (4): CD005479.
3. Cavasin H, Dola T, Uribe O. et al.Postoperative infectious morbidities of cesarean delivery in human immunodeficiency virus-infected women. Infect. Dis. Obstet. Gynecol. 2009; 2009: 827405.
4. Lapaire O, Irion O, Koch-Holch A. et al.Increased peri- and post-elective cesarean section morbidity in women infected with human immunodeficiency virus-1: a case-controlled multicenter study. Arch. Gynecol. Obstet. 2006; 274 (3): 165—169.
5. Maiques V., Garcia-Tejedor A., Diago V. et al.Perioperative cesarean delivery morbidity among HIV-infected women under highly active antiretroviral treatment: a case-control study. Eur. J. Obstet. Gynecol. Reprod. Biol. 2010; 153 (1): 27—31.
6. Louis J, Landon M. B., Gersnoviez R. J. et al.Perioperative morbidity and mortality among human immunodeficiency virus infected women undergoing cesarean delivery. Obstet. Gynecol. 2007; 110 (2 Pt 1): 385—390.
7. Sharma D., Spearman P.The impact of cesarean delivery on transmission of infectious agents to the neonate. Clin. Perinatol. 2008; 35 (2): 407—420, vii—viii.
8. Volmink J., Siegfried N. L., van der Merwe L., Brocklehurst P.Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database Syst. Rev. 2007; 24 (1): CD003510.
9. Watts D. H, Balasubramanian R., Maupin R. T. et al.Maternal toxicity and pregnancy complications in human immunodeficiency virus-infected women receiving antiretroviral therapy: PACTG 316. Am. J. Obstet. Gynecol. 2004; 190 (2): 506—516.
10. Mathew J., Maddali M. M., Fahr J.Prolonged muscle weakness following general anesthesia in a parturient on combined antiretroviral therapy-a case report. Middle East J. Anesthesiol. 2007; 19 (3): 673—678.
11. Vidal J. E., CliffordD., Ferreira C. M., Oliveira A. C.HIV-associated neuromuscular weakness syndrome in Brazil: report of the two first cases. Arq. Neuropsiquiatr. 2007; 65 (3B): 848—851.
12. Levine A. M.Anemia, neutropenia, and thrombocytopenia: pathogene-sis and evolving treatment options in HIV-infected patients CME.http://www.medscape.com/viewprogram/669_pnt
13. Sullivan P. S., Hanson D. L., Chu S. Y. et al.Epidemiology of anemia in human immunodeficiency virus infected persons: results from the mul-tistate adult and adolescent spectrum of HIV disease surveillance project. Blood 2008; 91 (1): 301—308.
14. Moore R. D., Forney D.Anemia in HIV infected patients receiving highly active antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 2002; 29 (1): 54—57.
15. Volberding P. A., Levine A. M., Dieterich D. et al.Anemia in HIV infection: clinical impact and evidence-based management strategies. Clin. Infect. Dis. 2004; 38 (10): 1454—1463.
16. Baylor M. S., Johann-Liang R.Hepatotoxicity associated with nevirap-ine use. J. Acquir Immune Defic. Syndr. 2004; 35 (5): 538—539.
17. Sturt A. S., Dokubo E. K., Sint T. T.Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women. Cochrane Database Syst. Rev. 2010; 17 (3): CD008440.
18. Boer K., NellenJ. F., PatelD. et al.The AmRo study: pregnancy outcome in HIV-1-infected women under effective highly active antiretroviral therapy and a policy of vaginal delivery. BJOG 2007; 114 (2): 148—155.
19. Suksomboon N., Poolsup N., Ket-Aim S.Systematic review of the efficacy of antiretroviral therapies for reducing the risk of mother-to-child transmission of HIV infection. J. Clin. Pharm. Ther. 2007; 32 (3): 293—311.
20. Stern J. O., Robinson P. A., Love J. et al.A comprehensive hepatic safety analysis of nevirapine in different populations of HIV infected patients. J. Acquir. Immune Defic. Syndr. 2003; 34 (Suppl 1): S21—S33.
21. Sax P. E., Kumar P.Tolerability and safety of HIV protease inhibitors in adults. J. Acquir. Immune Defic. Syndr. 2004; 37 (1): 1111 — 1124.
22. Crane H. M., Van Rompaey S. E., Kitahata M. M.Antiretroviral medications associated with elevated blood pressure among patients receiving highly active antiretroviral therapy. AIDS 2006; 20 (7): 1019—1026.
23. Evron S., Glezerman M., Harow E. et al.Human immunodeficiency virus: anesthetic and obstetric considerations. Anesth. Analg 2004; 98 (2): 503—511.
24. Turjanski N., Lloyd G. G.Psychiatric side-effects of medications: recent developments. Adv. Psychiatr. Treat. 2005; 11: 58—70.
25. Hignett R., Fernando R.Anesthesia for the pregnant HIV patient. Anesthesiol. Clin. 2008; 26 (1): 127—143, vii.
26. Treisman G. J., Kaplin Al.Neurologic and psychiatric complications of antiretroviral agents. AIDS 2002; 16 (9): 1201—1215.
27. Minkoff H., Augenbraun M.Antiretroviral therapy for pregnant women. Am. J. Obstet. Gynecol. 1997; 176 (2): 478—489.
28. de Andrade C. M., Duarte G., Quintana S. M. et al.Effect of antiretrovi-ral therapy on hemostasis in Brazilian pregnant women with HIV infection. Blood Coagul. Fibrinolysis 2007; 18 (8): 769—774.
29. Shen Y. M., FrenkelE. P.Thrombosis and a hypercoagulable state in HIV-infected patients. Clin. Appl. Thromb. Hemost. 2004; 10 (3): 277—280.
30. Jong E., Louw S., Meijers J. C. et al.The hemostatic balance in HIV-infected patients with and without antiretroviral therapy: partial restoration with antiretroviral therapy. AIDS Patient Care STDS 2009; 23 (12): 1001—1007.
31. Baluch A., Maass H., Rivera C. et al.Current perioperative management of the patient with HIV. Middle East J. Anesthesiol. 2009; 20 (2): 167—177.
32. Horlocker T. T., Wedel D. J., Benzon H. et al.Regional anesthesia in the anticoagulated patient: Defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Reg. Anesth. Pain Med. 2003; 28 (3): 172—197.
33. Avidan M. S., Groves P., Blott M. et al.Low complication rate associated with cesarean section under spinal anesthesia for HIV-1-infected women on antiretroviral therapy. Anesthesiology 2002; 97 (2): 320—324.
34. Bremerich D. H., Ahr A., Buchner S. et al.Anesthetic regimen for HIV positive parturients undergoing elective cesarean section. Anaesthesist 2003; 52 (12): 1124—1131.
35. Hughes S. C.HIV and anesthesia. Anesthesiol. Clin. North America. 2004; 22 (3): 379—404.
36. Kuczkowski K. M.Anesthetic considerations for the HIV-infected pregnant patient. Yonsei Med. J. 2004; 45 (1): 1—6.
37. Worszawski J., Tubiana R., Le Chenadec J. et al.Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort. AIDS 2008; 22 (2): 289—299.
Рецензия
Для цитирования:
Шифман Е.М., Вартанов В.Я., Хуторская Н.Н., Кругова Л.В. Осложнения антиретровирусной терапии и их коррекция в периоперационном периоде у ВИЧ-инфицированных беременных. Общая реаниматология. 2011;7(3):75. https://doi.org/10.15360/1813-9779-2011-3-75
For citation:
Shifman E.M., Vartanov V.Ya., Khutorskaya N.N., Krugova L.V. Antiretroviral Therapy Complications and Their Correction in HIV-Infected Pregnant Women in the Perioperative Period. General Reanimatology. 2011;7(3):75. (In Russ.) https://doi.org/10.15360/1813-9779-2011-3-75
Просмотров:
1782
Послать статью по эл. почте 